期刊文献+

临床分离鲍曼不动杆菌耐药性检测及其主动外排机制的确证

Detection of Drug Resistance of Clinical Separated Acinetobacter baumannii and Confirmation of Its Active Efflux Mechanism
原文传递
导出
摘要 目的对我院分离的鲍曼不动杆菌进行耐药性分析并初步探讨是否存在药物主动外排机制。方法K-B法对临床分离的鲍曼不动杆菌进行药敏试验,CCCP联合不同抗菌药物测定MIC值的变化进行主动外排机制的初步确证。结果75株鲍曼不动杆菌对临床常用抗生素均有不同程度耐药,CCCP处理前后MIC值均呈现不同程度变化,多种药物泵阳性株和泵阴性株的耐药率和敏感率差异有统计学意义(P<0.05)。结论临床鲍曼不动杆菌耐药形势严峻,75株试验菌株存在药物主动外排机制,其高度耐药性及多重耐药性可能与主动外排机制密切相关。 Objective To analyze the drug resistance of clinical separated Acinetobacter baumannii in our hospital,and to explore whether Acinetobacter baumannii efflux antibacterials actively.Methods K-B method was used to determine the drug resistance of clinical separated Acinetobacter baumannii.Influence of carbonyl cyanidem-chlorophenylhydrazone (CCCP) in Acinetobacter baumannii on minimal inhibitory concentrations (MICs) of various anti-microbial agents was detected to identify active efflux mechanism.Results Seventy-five strains of the clinical separated Acinetobacter baumannii had different-level resistance to antibacterials.CCCP had effect on the MICs of conventional anti-microbial agents to sensitive and resistant anti-microbial agents Acinetobacter baumannii strains.There were statistically significant differences in drug resistance rate and sensitive rate of positive and negative efflux pump strains(P0.05).Conclusions Situation of drug resistance is serious in the clinical separated Acinetobacter baumannii.Active drug efflux mechanism exists in 75 strains.High-level and multi-drug resistance may be closely associated with active drug efflux mechanism.
出处 《实用预防医学》 CAS 2010年第4期772-774,共3页 Practical Preventive Medicine
关键词 鲍曼不动杆菌 耐药性 主动外排系统 泵抑制剂 抗菌药物 Acinetobacter baumannii Drug resistance Active efflux system Pump inhibitor Antimicrobial agent
  • 相关文献

参考文献5

二级参考文献36

  • 1王露霞,石凌波,徐德兴,曾丽英,罗春梅.应用纸片扩散法与梯度浓度法测定不动杆菌属的耐药性[J].第一军医大学学报,2003,23(5):469-471. 被引量:10
  • 2李家泰,王彤,贾延军,李曼宁.临床分离耐药菌中超广谱β-内酰胺酶特性研究[J].中国临床药理学杂志,1996,12(2):81-84. 被引量:15
  • 3陆春雨,张正.鲍曼不动杆菌多重耐药与胞膜主动外排作用关系的研究[J].北京医学,2007,29(6):356-360. 被引量:11
  • 4Hogan D ,Kolter R. Why are bacteria refractory to antimicrobials[ J]. Curt Opin Microbiol,2002,5 ( 5 ) :472-477.
  • 5Higgins P G, Wisplinghoff H, Stefanik D, a al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii [ J ]. J Antimicrob Chemother,2004,54(4) :821-823.
  • 6Peleg A Y, Adams J, Paterson D L. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii[J]. Antimicrob Agents Chemother,2007,51 ( 6 ) : 2065-2069.
  • 7Lee A, Mao W, Warren M S, et al. Interplay between efflux pumps may provide either additive or muhiplicative effects on drug resistance [ J]. J Bacterio1,2000,182( 11 ) :3142-3150.
  • 8Oethinger M, Kern W V, Jellen-Ritter A S, et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB ettlux pump[ J]. Antimicrob Agents Chemother,2000,44 ( 1 ) :10-13.
  • 9Piddock L J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria [ J]. Clin Microbiol Rev, 2006, 19 (2) :382-402.
  • 10Putman M, van Veen H W, Konings W N. Molecular properties of bacterial multidrug transporters [ J ]. Microbiol Mol Biol Rev, 2000,64 (4) :672-693.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部